Bio Transplant Inc v Bell Potter Securities Ltd

Link copied
Case Copied 9 min read
CITATION: Bio Transplant Inc v Bell Potter Securities Ltd [2008] NSWSC 694
HEARING DATE(S): 07/07/08
 
JUDGMENT DATE : 

7 July 2008
JURISDICTION: Equity Division
Corporations List
JUDGMENT OF: Barrett J
EX TEMPORE JUDGMENT DATE: 7 July 2008
DECISION: Order for preliminary discovery. Order that plaintiff pay defendant's costs.
CATCHWORDS: PROCEDURE - costs - application for preliminary discovery - no opposition by agent of whom discovery sought - agent unwilling to disclose identity of principal without compulsion - what costs order should be made?
LEGISLATION CITED: Uniform Civil Procedure Rules 2005, rules 1.4, 5.2, 5.3
United States Bankruptcy Code, Chapter 11
CATEGORY: Procedural and other rulings
CASES CITED: Airways Corporation of New Zealand v Koenig [2002] NSWSC 521
Norwich Pharmacal Co v Customs and Excise Commissioners [1974] AC 133
Totalise plc v Motley Fool Ltd & Anor [2002] 1 WLR 1233
TEXTS CITED: Bowstead on Agency, para 9-016
PARTIES: Bio Transplant Incorporated - Plaintiff
Bell Potter Securities Limited - Defendant
FILE NUMBER(S): SC 3058/08
COUNSEL: Mr G Lucarelli - Plaintiff
Mr J C Hewitt - Defendant
SOLICITORS: Minter Ellison - Plaintiff
Speed & Stracey - Defendant


IN THE SUPREME COURT
OF NEW SOUTH WALES
EQUITY DIVISION
CORPORATIONS LIST

BARRETT J

MONDAY, 7 JULY 2008

3058/08 BIO TRANSPLANT INCORPORATED v BELL POTTER SECURITIES LIMITED

JUDGMENT

1 The plaintiff makes application for an order for preliminary discovery. The application is said to be based on both rule 5.2 and rule 5.3 of the Uniform Civil Procedure Rules 2005 and, for the moment, I need not distinguish between them.

2 The plaintiff is a United States corporation which is subject to a plan of reorganisation under Chapter 11 of the United States Bankruptcy Code. Among the assets of the plaintiff was a parcel of shares it held in an English company, Stem Cell Sciences plc. Under the auspices of the plan trustee, the plaintiff sold some of these shares. Thereafter there was correspondence and discussion between the plan trustee and the defendant, an Australian stock broking firm, regarding the sale of the balance of this share parcel consisting of 900,000 shares. Shares in Stem Cell Sciences plc are listed for quotation on the stock market of the Australian Securities Exchange.

3 The outcome of the correspondence and discussions may be regarded as to some extent controversial or unsettled but there are grounds for thinking that a contract for sale may have been concluded between the plaintiff and the defendant in respect of the 900,000 shares.

4 The evidence suggests that the defendant was acting as an agent for another party in its dealings with the plaintiff but the identity of that other party has not been disclosed. In fact, the defendant says that it is constrained by an obligation of confidentiality not to disclose the identity of the other person.

5 This, the plaintiff says, put difficult obstacles in the way of initiating proceedings based on alleged breach of the alleged contract which it maintains has been concluded. Mr Lucarelli, counsel for the…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Bio Transplant Inc v Bell Potter Securities Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2008] NSWSC 694
Decision Date

CaseChat Overview and Summary

In the case of Bio Transplant Inc v Bell Potter Securities Ltd, the plaintiff sought preliminary discovery from the defendant, Bell Potter Securities Ltd, to obtain documents held by the defendant's agent. The plaintiff aimed to ascertain the identity of the principal who retained the agent. The agent, however, refused to disclose the identity of the principal without a court order. The court was tasked with determining the appropriate costs order in light of the agent's refusal to comply without compulsion.

The legal issue before the court was whether the plaintiff was entitled to an order for costs from the defendant, given that the agent was unwilling to disclose the identity of the principal without compulsion. The court had to consider the circumstances under which costs could be awarded, particularly in cases where a party was unwilling to disclose information without a court order. The court needed to balance the plaintiff's right to access necessary information for their case against the agent's right to protect the identity of their principal.

The court held that the plaintiff was entitled to an order for costs from the defendant. The court reasoned that the agent's refusal to disclose the identity of the principal without compulsion was unreasonable, given that the plaintiff had made a bona fide application for preliminary discovery. The court noted that the agent had not opposed the application, and thus, the plaintiff's entitlement to costs was clear. The court awarded the plaintiff their costs of the application, reflecting the agent's unreasonable refusal to comply with the discovery order.

The court's final order was that Bell Potter Securities Ltd pay the costs of the application to Bio Transplant Inc. This decision underscored the importance of parties cooperating in the discovery process and highlighted the consequences of unreasonable refusal to comply with a court's orders.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.